Global Proton Therapy Market 2014-2018
出 版 商：Infiniti Research
出版日期：2014/10/15
頁 數：63頁
文件格式：PDF
價 格：
USD 2,500 (Single-User License)
USD 2,800 (Multi-User License)
USD 3,500 (Global-User License)
USD 2,800 (Multi-User License)
USD 3,500 (Global-User License)
About Proton Therapy
Proton therapy is a type of particle therapy which is used to treat cancer patients by means of proton beams irradiation. The main advantage of proton therapy is that while destroying the target malignant cells, it causes minimal damage to the surrounding cells. Proton therapy uses the ionization technique to inhibit cell proliferation. Protons move slowly through the body and interact with electrons and discharge energy. The MD Anderson Proton Therapy Center is the pioneer in this technology and also initiated the pencil beam proton therapy, which is also known as scanning beam and intensity modulated proton therapy.
TechNavio's analysts forecast the Global Proton Therapy market to grow at a CAGR of 9.50 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Proton Therapy market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various products used for the treatment of cancer using the proton beam therapy.
TechNavio's report, Global Proton Therapy Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Global Proton Therapy market landscape and its growth prospects in the coming years in the Americas, and the EMEA and APAC regions. The report also includes a discussion of the key vendors operating in this market.
Key Regions
‧ Americas
‧ APAC
‧ EMEA
Key Vendors
‧ Hitachi
‧ IBA Proton Therapy
‧ Mitsubishi Electric
‧ Varian Medical Systems
Other Prominent Vendors
‧ Accuray
‧ Advanced Oncotherapy
‧ Advanced Particle Therapy
‧ Advanced Proton Solutions
‧ Best Particle Therapy
‧ Compact Particle Acceleration
‧ Elekta
‧ GE Healthcare
‧ Mevion Medical Systems
‧ Optivus Proton Therapy
‧ Procure Treatment Center
‧ ProNova Solutions
‧ ProTom International
‧ SAH Global
‧ Siemens
‧ Sumitomo Heavy Industries
‧ Toshiba
Market Driver
‧ Technological Advancement
‧ For a full, detailed list, view our report
Market Challenge
‧ High Cost of Treatment
‧ For a full, detailed list, view our report
Market Trend
‧ Rise in Demand
‧ For a full, detailed list, view our report
Key Questions Answered in this Report
‧ What will the market size be in 2018 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
‧ What are the market opportunities and threats faced by the key vendors?
‧ What are the strengths and weaknesses of the key vendors?
Proton therapy is a type of particle therapy which is used to treat cancer patients by means of proton beams irradiation. The main advantage of proton therapy is that while destroying the target malignant cells, it causes minimal damage to the surrounding cells. Proton therapy uses the ionization technique to inhibit cell proliferation. Protons move slowly through the body and interact with electrons and discharge energy. The MD Anderson Proton Therapy Center is the pioneer in this technology and also initiated the pencil beam proton therapy, which is also known as scanning beam and intensity modulated proton therapy.
TechNavio's analysts forecast the Global Proton Therapy market to grow at a CAGR of 9.50 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Proton Therapy market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various products used for the treatment of cancer using the proton beam therapy.
TechNavio's report, Global Proton Therapy Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Global Proton Therapy market landscape and its growth prospects in the coming years in the Americas, and the EMEA and APAC regions. The report also includes a discussion of the key vendors operating in this market.
Key Regions
‧ Americas
‧ APAC
‧ EMEA
Key Vendors
‧ Hitachi
‧ IBA Proton Therapy
‧ Mitsubishi Electric
‧ Varian Medical Systems
Other Prominent Vendors
‧ Accuray
‧ Advanced Oncotherapy
‧ Advanced Particle Therapy
‧ Advanced Proton Solutions
‧ Best Particle Therapy
‧ Compact Particle Acceleration
‧ Elekta
‧ GE Healthcare
‧ Mevion Medical Systems
‧ Optivus Proton Therapy
‧ Procure Treatment Center
‧ ProNova Solutions
‧ ProTom International
‧ SAH Global
‧ Siemens
‧ Sumitomo Heavy Industries
‧ Toshiba
Market Driver
‧ Technological Advancement
‧ For a full, detailed list, view our report
Market Challenge
‧ High Cost of Treatment
‧ For a full, detailed list, view our report
Market Trend
‧ Rise in Demand
‧ For a full, detailed list, view our report
Key Questions Answered in this Report
‧ What will the market size be in 2018 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
‧ What are the market opportunities and threats faced by the key vendors?
‧ What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Significance of Proton Therapy
08. List of Proton Therapy Centers
09. Reimbursement Scenario
10. Geographical Segmentation
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2013
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 Hitachi
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Business Segmentation
19.1.4 Business Segmentation by Revenue 2014
19.1.5 Business Segmentation by Revenue 2013 and 2014
19.1.6 Geographical Segmentation by Revenue 2014
19.1.7 Business Strategy
19.1.8 SWOT Analysis
19.2 IBA Proton Therapy
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 SWOT Analysis
19.3 Mitsubishi Electric
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Business Segmentation by Revenue 2013
19.3.4 Business Segmentation by Revenue 2012 and 2013
19.3.5 Geographical Segmentation by Revenue 2013
19.3.6 Business Strategy
19.3.7 Recent Developments
19.3.8 SWOT Analysis
19.4 Varian Medical Systems
19.4.1 Key Facts
19.4.2 Business Description
19.4.3 Business Segmentation
19.4.4 Revenue Segmentation by Business
19.4.5 Segmental Revenue Comparison - 2013 and 2012
19.4.6 Sales by Geographical Segmentation
19.4.7 Business Strategy
19.4.8 Key Developments
19.4.9 SWOT Analysis
20. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Proton Therapy Market 2013-2018 (US$ million)
Exhibit 3: Dose Determination in Proton Therapy: Bragg Peak
Exhibit 4: Proton Deposition Curve
Exhibit 5: List of Proton Therapy Centers in the US 2013
Exhibit 6: List of Proton Therapy Centers with IBA 2013
Exhibit 7: Comparison of the Number of Proton Therapy Centers and the Patient Base Being Served Globally
Exhibit 8: Current and Expected Number of Proton Therapy Rooms Globally
Exhibit 9: Global Proton Therapy Market by Geography Segmentation 2013
Exhibit 10: Global Proton Therapy Market Share Analysis 2018
Exhibit 11: Comparison of the Operational and Ordered Proton Therapy Systems of the Major Vendors
Exhibit 12: Comparison of the Patient Base Served by Vendors 2013
Exhibit 13: Number of Patients Treated by IBA Proton Therapy 2012 - 2015 (Expected)
Exhibit 14: Sales Comparison of IBA's Proton Therapy System 2007-2013 (US$ million)
Exhibit 15: Hitachi: Business Segmentation 2014
Exhibit 16: Hitachi: Business Segmentation by Revenue 2014
Exhibit 17: Hitachi: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 18: Hitachi: Geographical Segmentation by Revenue 2014
Exhibit 19: Global Proton Therapy Market: Business Segmentation by Revenue 2013
Exhibit 20: Mitsubishi: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 21: Mitsubishi Electric: Geographical Segmentation by Revenue 2013
Exhibit 22: Business Segmentation of Varian Medical Systems Inc.
Exhibit 23: Revenue Segmentation of Varian Medical Systems Inc. (2013)
Exhibit 24: Revenue Comparison (US$ million)
Exhibit 25: Revenue Segmentation of Varian Medical Systems Inc. by Geography (2013)
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Significance of Proton Therapy
08. List of Proton Therapy Centers
09. Reimbursement Scenario
10. Geographical Segmentation
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2013
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 Hitachi
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Business Segmentation
19.1.4 Business Segmentation by Revenue 2014
19.1.5 Business Segmentation by Revenue 2013 and 2014
19.1.6 Geographical Segmentation by Revenue 2014
19.1.7 Business Strategy
19.1.8 SWOT Analysis
19.2 IBA Proton Therapy
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 SWOT Analysis
19.3 Mitsubishi Electric
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Business Segmentation by Revenue 2013
19.3.4 Business Segmentation by Revenue 2012 and 2013
19.3.5 Geographical Segmentation by Revenue 2013
19.3.6 Business Strategy
19.3.7 Recent Developments
19.3.8 SWOT Analysis
19.4 Varian Medical Systems
19.4.1 Key Facts
19.4.2 Business Description
19.4.3 Business Segmentation
19.4.4 Revenue Segmentation by Business
19.4.5 Segmental Revenue Comparison - 2013 and 2012
19.4.6 Sales by Geographical Segmentation
19.4.7 Business Strategy
19.4.8 Key Developments
19.4.9 SWOT Analysis
20. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Proton Therapy Market 2013-2018 (US$ million)
Exhibit 3: Dose Determination in Proton Therapy: Bragg Peak
Exhibit 4: Proton Deposition Curve
Exhibit 5: List of Proton Therapy Centers in the US 2013
Exhibit 6: List of Proton Therapy Centers with IBA 2013
Exhibit 7: Comparison of the Number of Proton Therapy Centers and the Patient Base Being Served Globally
Exhibit 8: Current and Expected Number of Proton Therapy Rooms Globally
Exhibit 9: Global Proton Therapy Market by Geography Segmentation 2013
Exhibit 10: Global Proton Therapy Market Share Analysis 2018
Exhibit 11: Comparison of the Operational and Ordered Proton Therapy Systems of the Major Vendors
Exhibit 12: Comparison of the Patient Base Served by Vendors 2013
Exhibit 13: Number of Patients Treated by IBA Proton Therapy 2012 - 2015 (Expected)
Exhibit 14: Sales Comparison of IBA's Proton Therapy System 2007-2013 (US$ million)
Exhibit 15: Hitachi: Business Segmentation 2014
Exhibit 16: Hitachi: Business Segmentation by Revenue 2014
Exhibit 17: Hitachi: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 18: Hitachi: Geographical Segmentation by Revenue 2014
Exhibit 19: Global Proton Therapy Market: Business Segmentation by Revenue 2013
Exhibit 20: Mitsubishi: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 21: Mitsubishi Electric: Geographical Segmentation by Revenue 2013
Exhibit 22: Business Segmentation of Varian Medical Systems Inc.
Exhibit 23: Revenue Segmentation of Varian Medical Systems Inc. (2013)
Exhibit 24: Revenue Comparison (US$ million)
Exhibit 25: Revenue Segmentation of Varian Medical Systems Inc. by Geography (2013)
